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tion. Unexpected in vivo performance of a mechanical heart valve
should be elucidated thoroughly and careful follow-up of affected
patients is warranted.
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Cardiac papillary muscle hemangioma
Andrew E. Newcomb, MBBS, FRACS,a Stefano Pelenghi, MD,a Jacek Karski, MD,b Jagdish Butany, MBBS, MS, FRCPC,c
and Tirone E. David, MD, FRCS(C),a Toronto, Ontario, Canada
Arare case of left ventricular hemangioma in combina-tion with mitral valve prolapse is reported. The neo-plasm was seen close to the tip of the posterior pap-illary muscle. The definitive diagnosis was made at
the time of postresection pathologic examination. A literature
review confirms the need for resection, if possible.
Clinical Summary
An echocardiogram on a 40-year-old man being observed for
mitral valve regurgitation revealed a 1.4-cm diameter mass on the
posterior papillary muscle. The mass had not been noted on pre-
vious examination 3 years prior. History and physical examination
were unremarkable. An angiogram confirmed 2 mitral regurgi-
tation. Results of all other investigations were within normal
limits. A clinical diagnosis of myxoma was made, and to avoid any
chance of tumor embolization, urgent surgery was scheduled.
An intraoperative transesophageal echocardiogram (TEE) con-
firmed A2 prolapse and a heterogeneous 1.7-cm diameter mass in the
left ventricle attached to chordae tendineae adjacent to the postero-
lateral papillary muscle (Figure 1). Using cardiopulmonary bypass
and hypothermic arrest, we opened the left atrium wide through the
interatrial groove. A spherical mass attached to the medial portion of
the anterior trunk of the posterior papillary muscle, approximately 1
cm below the level where the chordae tendineae attach, was identified
(Figure 2) and removed along with a 3- to 4-mm rim of papillary
muscle around the base (Figure 2, inset). The remaining muscle
looked viable and strong. The A2 prolapse was corrected with 6
polytetrafluoroethylene neochordae (Gore-Tex; registered trade mark
of W. L. Gore & Associates, Inc, Flagstaff, Ariz) between the poste-
rior papillary muscle and the free margin of the leaflet. A posterior
annuloplasty band with a Medtronic Simplici-T (Medtronic, Inc,
Minneapolis, Minn) 64 mm in length was performed.
The postprocedure TEE showed normal valvular function. The
postoperative course was uneventful and the patient was discharged
home 5 days after the operation. Follow-up review at 2 months
showed no mitral regurgitation or tumor recurrence.
Histopathologic examination revealed a 1.5-cm diameter mass
comprising vascular channels (CD31 positive cells on immunohis-
tochemical staining [antibodies from Dako Diagnostics, Missis-
sauga, Ontario, Canada]) with the histologic appearance of hem-
angioma. There were small (capillary) and large (cavernous)
vascular structures of varying sizes with variable amounts of
endothelial cells and smooth muscle cells separated by a loose,
partly myxoid matrix. The smooth muscle actin stain was also
positive in cells surrounding the vascular channels.
Discussion
Primary cardiac tumors are rare and most are benign. Hemangio-
mas account for 5% to 10% of these benign tumors.1 They may
present at any age and there is a slight male preponderance.
Hemangiomas may be found in any layer of the heart and in any
chamber; however, there is a tendency for the right heart and left
atrium to be more frequently involved.2
Microscopically, these are composed of vascular endothelial
cells and may be classified into capillary, cavernous, venous, or
racemose in nature.3 Most hemangiomas are small subendocardial
bluish nodules and range in size from 2 to 3.5 cm. They may be
sessile or polypoid and are mostly solitary.2 These tumors are
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usually asymptomatic, but symptoms may reflect the anatomic
location of the tumor. They have been reported to induce arrhyth-
mias, coronary insufficiency, pericardial effusions, effort dyspnea,
outflow tract obstruction, and congestive heart failure.3
In our patient, myxoma was suspected on the basis of TEE, and
intraoperative assessment also led the surgical team to suspect
myxoma. The definitive diagnosis was only completed with formal
histologic evaluation. Echocardiographic scanning or cardiac cath-
eterization will usually establish a diagnosis of cardiac tumor by
showing an intracavity filling defect and a tumor blush,2,3 but more
intensive diagnostic examinations are needed to correctly define
the type of tumor.4
Surgical resection is desirable but may be impossible depend-
ing on the tumor’s location. Because the diagnosis of these rare
tumors is often made post mortem, the natural history is un-
known,2,3 so a definitive management plan in the setting of an
unresectable lesion cannot be recommended. Some reported cases
of tumor debulking have produced long-term benefits,3,5 but there
have also been reports of recurrence after complete extirpation.2
This case confirms that hemangioma is a rare asymptomatic
tumor that may be identified with the increase in noninvasive
cardiac investigations. It also reinforces the need for surgical
intervention for risk reduction and definitive histologic diagnosis.
References
1. Burke A, Virmani R. Tumors of the heart and great vessels. In: Rosai J,
Sobin LH, editors. Atlas of tumor pathology. 3rd series, fascicle 16.
Washington, DC: Armed Forces Institute of Pathology; 1996. p. 80-6.
2. Chao JC, Reyes CV, Hwang MH. Cardiac hemangioma. South Med J.
1990;83:44-7.
3. Brizard C, Latremouille C, Jebara VA, Acar C, Fabiani JN, Deloche A,
et al. Cardiac hemangiomas. Ann Thorac Surg. 1993;56:390-4.
4. Zeina AR, Zaid G, Sharif D, Rosenshein U, Barmeir E. Huge pericardial
hemangioma imaging. Circulation. 2007:115:e315-7.
5. Grebenc ML, Rosado de Christenson ML, Burke AP, Green CE, Galvin
JR. Primary cardiac and pericardial neoplasms: radiologic-pathologic
correlation. Radiographics. 2000;20:1073-103.
Figure 1. Intraoperative transgastric long-axis TEE image show-
ing the mass and its relationship to the posterior papillary muscle
(POST PM).
Figure 2. Clinical photograph of the mass confirming the position
as seen through the mitral valve (white arrow). Inset, Resected
specimen with attached papillary muscle.
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